









Choosing the best match of 
the journal’s keywords to your 
work will likely result in better 
match to reviewers with 
expertise in your interest area. 
It may also help to speed the 
review process.: 
Optional Terms: You have the 
option to add additional key 
words that are not on the 
journal's list to more 
specifically categorize your 
submission.: 




Page 1 of 35 Arthritis Care & Research
This is the author manuscript accepted for publication and has undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to differences
between this version and the Version record. Please cite this article as doi:10.1002/acr.22893.










Cochin Hand Function Scale-6 
 
 1
Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome 
Measures: Development and Validation of the Cochin Hand Function Scale-6 – A 
Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study 
 
Alexander W. Levis, BSc
1,2
; Daphna Harel, PhD
3,4





; Luc Mouthon, MD, PhD
7,8
; Serge Poiraudeau, MD, PhD
 7,9,10
; Susan J. Bartlett, 
PhD
11,12
; Dinesh Khanna, MD, MS
 13
; Vanessa L. Malcarne, PhD
14,15
; Maureen Sauve, BA
16,17
; 
Cornelia H.M. van den Ende, PhD
18
; Janet L. Poole, PhD, OTR/L
19












Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, 
Canada; 
2
Department of Epidemiology, Biostatistics, and Occupational Health, McGill 
University, Montréal, Québec, Canada; 
3
PRIISM Applied Statistics Center, New York 
University, New York, New York, USA; 
4
Department of Humanities and Social Sciences in the 
Professions, New York University, New York, New York, USA 
5
Department of Psychiatry, 
McGill University, Montréal, Québec, Canada; 
6
Behavioural Science Institute, Clinical 
Psychology, Radboud University, Nijmegen, the Netherlands; 
7
Université Paris Descartes, 
Assistance Publique-Hôpitaux de Paris, Paris, France; 
8
Service de Médecine Interne, Hôpital 
Cochin, Paris, France; 
9
Service de Médecine Physique et Réadaptation, Hôpital Cochin, Paris, 
France; 
10
IFR Handicap INSERM, Paris, France; 
11
McGill University Health Center, Montréal, 
Québec, Canada; 
12
Department of Medicine, McGill University, Montréal, Québec, Canada; 
13
University of Michigan Scleroderma Program, Ann Arbor, MI; 
14
Department of Psychology, 
San Diego State University, San Diego, California, USA; 
15
San Diego State 
Page 2 of 35
John Wiley & Sons, Inc.
Arthritis Care & Research










Cochin Hand Function Scale-6 
 
 2
University/University of California, San Diego Joint Doctoral Program in Clinical Psychology, 
San Diego, California, USA; 
16
Scleroderma Society of Ontario, Hamilton, Ontario, Canada; 
17
Scleroderma Society of Canada, Hamilton, Ontario, Canada; 
18
Department of Rheumatology, 
Sint Maartenskliniek, The Netherlands; 
19
Occupational Therapy Graduate Program, University 
of New Mexico, USA; 
20
Leiden University Medical Center, Leiden, The Netherlands; 
21
NVLE 
Dutch patient organization for systemic autoimmune diseases, Utrecht, The Netherlands; 
Departments of 
22





Nursing, McGill University, Montreal, Quebec, Canada; 
25
SPIN Investigators: Murray Baron, 
McGill University, Montréal, Québec, Canada; Dan Furst, University of California, Los Angeles, 
California, USA; Karen Gottesman, Scleroderma Foundation, Los Angeles, California, USA; 
Frank van den Hoogen, Radboud University Medical Center and Sint Maartenskliniek, 
Nijmegen, The Netherlands; Maureen D. Mayes, University of Texas Health Science Center, 
Houston, Texas, USA; Warren R. Nielson, St. Joseph’s Health Care, London, Ontario, Canada; 
Robert Riggs, Scleroderma Foundation, Danvers, Massachusetts, USA; Fredrick Wigley, Johns 
Hopkins University School of Medicine, Baltimore, Maryland, USA; Shervin Assassi, University 
of Texas Health Science Center, Houston, Texas, USA; Isabelle Boutron, Université Paris 
Descartes, and Assistance Publique-Hôpitaux de Paris, Paris, France; Angela Costa Maia, 
University of Minho, Braga, Portugal; Ghassan El-Baalbaki, Université du Québec à Montréal, 
Montréal, Québec, Canada; Carolyn Ells, McGill University, Montréal, Québec, Canada; Kim 
Fligelstone, Scleroderma Society, London, UK; Catherine Fortune, Scleroderma Society of 
Ontario, Hamilton, Ontario, Canada; Tracy Frech, University of Utah, Salt Lake City, Utah, 
USA; Dominique Godard, Association des Sclérodermiques de France, Sorel-Moussel, France; 
Marie Hudson, Jewish General Hospital and McGill University, Montréal, Québec, Canada; Ann 
Page 3 of 35
John Wiley & Sons, Inc.
Arthritis Care & Research










Cochin Hand Function Scale-6 
 
 3
Impens, Midwestern University, Downers Grove, Illinois, USA; Yeona Jang, McGill University, 
Montréal, Québec, Canada; Sindhu R. Johnson, Toronto Scleroderma Program, Mount Sinai 
Hospital, Toronto Western Hospital, and University of Toronto, Toronto, Ontario, Canada; Ann 
Tyrell Kennedy, Federation of European Scleroderma Associations, Dublin, Ireland; Maggie 
Larche, McMaster University, Hamilton, Ontario, Canada; Catarina Leite, University of Minho, 
Braga, Portugal; Carlo Marra, Memorial University, St. John’s, Newfoundland, Canada; Karen 
Nielsen, Scleroderma Society of Ontario, Hamilton, Ontario, Canada; Janet Pope, University of 
Western Ontario, London, Ontario, Canada; Alexandra Portales, Asociación Española de 
Esclerodermia, Madrid, Spain; Tatiana Sofia Rodriguez Reyna, Instituto Nacional de Ciencias 
Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Russell J. Steele, McGill 
University, Montréal, Québec, Canada; Maria E. Suarez-Almazor, University of Texas MD 
Anderson Cancer Center, Houston, Texas, USA; Durhane Wong-Rieger, Canadian Organization 
for Rare Disorders, Toronto, Ontario, Canada; Alexandra Albert, Université Laval, Québec, 
Québec, Canada; Guylaine Arsenault, Sherbrooke University, Sherbrooke, Québec, Canada; 
Lyne Bissonnette, Sherbrooke University, Sherbrooke, Québec, Canada; Gilles Boire, 
Sherbrooke University, Sherbrooke, Québec, Canada; Alessandra Bruns, Sherbrooke University, 
Sherbrooke, Québec, Canada; Patricia Carreira, Servicio de Reumatologia del Hospital 12 de 
Octubre, Madrid, Spain; Lorinda Chung, Stanford University, Stanford, California, USA; Pierre 
Dagenais, Sherbrooke University, Sherbrooke, Québec, Canada; Christopher Denton, Royal Free 
London Hospital, London, UK; Robyn Domsic, University of Pittsburgh, Pittsburgh, 
Pennsylvania, USA; James V. Dunne, St. Paul's Hospital and University of British Columbia, 
Vancouver, British Columbia, Canada; Paul Fortin, Université Laval, Québec, Québec, Canada; 
Anna Gill, Royal Free London Hospital, London, UK; Jessica Gordon, Hospital for Special 
Page 4 of 35
John Wiley & Sons, Inc.
Arthritis Care & Research










Cochin Hand Function Scale-6 
 
 4
Surgery, New York City, New York, USA; Genevieve Gyger, Jewish General Hospital and 
McGill University, Montréal, Québec, Canada; Ariane L. Herrick, University of Manchester, 
Salford Royal NHS Foundation Trust, Manchester, UK; Monique Hinchcliff, Northwestern 
University, Chicago, Illinois, USA; Alena Ikic, Université Laval, Québec, Québec, Canada; Niall 
Jones, University of Alberta, Edmonton, Alberta, Canada; Artur Jose de B. Fernandes, 
Sherbrooke University, Sherbrooke, Québec, Canada; Suzanne Kafaja, University of California, 
Los Angeles, California, USA; Nader Khalidi, McMaster University, Hamilton, Ontario, Canada; 
Benjamin Korman, Northwestern University, Chicago, Illinois, USA; Patrick Liang, Sherbrooke 
University, Sherbrooke, Québec, Canada; Joanne Manning, Salford Royal NHS Foundation 
Trust, Salford, UK; Ariel Masetto, Sherbrooke University, Sherbrooke, Québec, Canada; David 
Robinson, University of Manitoba, Winnipeg, Manitoba, Canada; Sophie Roux, Sherbrooke 
University, Sherbrooke, Québec, Canada; Elena Schiopu, University of Michigan, Ann Arbor, 
Michigan, USA; Doug Smith, University of Ottawa, Ottawa, Ontario, Canada; Robert Spiera, 
Hospital for Special Surgery, New York, New York, USA; Virginia Steen, Georgetown 
University, Washington, DC, USA; Evelyn Sutton, Dalhousie University, Halifax, Nova Scotia, 
Canada; Carter Thorne, Southlake Regional Health Centre, Newmarket, Ontario, Canada; John 
Varga, Northwestern University, Chicago, Illinois, USA; Pearce Wilcox, St. Paul's Hospital and 
University of British Columbia, Vancouver, British Columbia, Canada; Vanessa C. Delisle, 
Jewish General Hospital and McGill University, Montréal, Québec, Canada; Claire Fedoruk, 
Jewish General Hospital, Montréal, Québec, Canada; Rina S. Fox, San Diego State University 
and University of California, San Diego, San Diego, California, USA; Shadi Gholizadeh, San 
Diego State University and University of California, San Diego, San Diego, California, USA; 
Lisa R. Jewett, Jewish General Hospital and McGill University, Montréal, Québec, Canada; 
Page 5 of 35
John Wiley & Sons, Inc.
Arthritis Care & Research










Cochin Hand Function Scale-6 
 
 5
Brooke Levis, Jewish General Hospital and McGill University, Montréal, Québec, Canada; 
Katherine Milette, Jewish General Hospital and McGill University, Montréal, Québec, Canada; 
Sarah D. Mills, San Diego State University and University of California, San Diego, San Diego, 
California, USA; Mia R. Pepin, Jewish General Hospital, Montréal, Québec, Canada; Jennifer 
Persmann, Université du Québec à Montréal, Montréal, Québec, Canada. 
 
Financial Support: SPIN is funded by a Canadian Institutes of Health Research (CIHR) 
Emerging Team Grant for Rare Diseases (PI, Thombs; TR3-119192). In addition to CIHR 
funding, SPIN has received institutional contributions from the Lady Davis Institute for Medical 
Research of the Jewish General Hospital, Montréal, Canada and from McGill University, 
Montréal, Canada. SPIN has also received support from the Scleroderma Society of Ontario, the 
Scleroderma Society of Canada, and Sclérodermie Québec. Mr. Levis was supported by a CIHR 
Institute of Musculoskeletal Health and Arthritis Studentship in Musculoskeletal Health and 
Arthritis. Dr. Harel was supported by NYU start-up research grants and SPIN. Dr. Kwakkenbos 
was supported by a CIHR Banting Postdoctoral Fellowship. Dr. Thombs was supported by an 
Investigator Salary Award from the Arthritis Society. 
 
Word Count: 3,777 
 
Address for Correspondence: 
Daphna Harel, PhD; 246 Greene Street, 3
rd
 floor, New York NY, 10003; Tel (212) 992-6701; E-
mail: daphna.harel@nyu.edu 
Page 6 of 35
John Wiley & Sons, Inc.
Arthritis Care & Research














Objective: The objective was to develop and validate a short form of the Cochin Hand Function 
Scale (CHFS), which measures hand disability, for use in systemic sclerosis, using objective 
criteria and reproducible techniques. 
Methods: Responses on the 18-item CHFS were obtained from English-speaking patients 
enrolled in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort. CHFS 
unidimensionality was verified using confirmatory factor analysis, and an item response theory 
model was fit to CHFS items. Optimal test assembly (OTA) methods identified a maximally 
precise short form for each possible form length between 1 and 17 items. The final short form 
selected was the form with the least number of items that maintained statistically equivalent 
convergent validity, compared to the full-length CHFS, with the Health Assessment 
Questionnaire - Disability Index (HAQ-DI) and Physical Function domain of PROMIS-29. 
Results: There were 601 patients included. A 6-item short form of the CHFS (CHFS-6) was 
selected. The CHFS-6 had a Cronbach’s alpha of 0.93. Correlations of the CHFS-6 summed 
score with HAQ-DI (r = 0.79) and PROMIS-29 Physical Function (r = -0.54) were statistically 
equivalent to the CHFS (r = 0.81, r = -0.56). The correlation with the full CHFS was high (r = 
0.98). 
Conclusion: The OTA procedure generated a valid short form of the CHFS with minimal loss of 
information compared to the full-length form. The OTA method used was based on objective, 
pre-specified criteria, but should be further studied for viability as a general procedure for 
shortening patient reported outcome measures in health research. 
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Significance and Innovation: 
• Valid and reliable short forms of patient-reported outcome (PRO) measures can reduce 
patient burden and increase research capacity. 
• There are no standard methods for developing short forms to maximize information. 
• This study showed that optimal test assembly (OTA) and equivalence testing methods 
may be used to create short forms objectively and reproducibly. 
• The Cochin Hand Function Scale-6 was developed using OTA and equivalency methods 
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Patient-reported outcomes (PROs) assess patient health, well-being, and treatment 
response based on patient perspectives (1,2). In rheumatic diseases, PROs, such as quality-of-life 
and functional ability, are as important to many patients as survival (3). Inclusion of PROs has 
become central in many clinical trials and cohort-based observational studies (4). Thus, efficient 
measurement of PROs is essential to limit both cost of patient cohorts and burden to patients who 
may be asked to respond to many different scales.  
In rare diseases, including systemic sclerosis (SSc), cohorts designed to collect medical 
and PRO data from large numbers of patients require collaborations that span countries, 
languages, and clinical settings. SSc is a chronic, multisystem autoimmune disorder 
characterized by fibrotic changes to the skin, joints and tendons, as well as vascular injury (5,6). 
Large SSc multinational cohorts include the European League Against Rheumatism Scleroderma 
Trials and Research cohort (7) and the Scleroderma Patient-centered Intervention Network 
(SPIN) Cohort (8), among others (9).  
Digital ulcers, contractures and deformities of the hand, which lead to decreased flexion, 
limited extension and reduced thumb abduction, play a major role in functional disability among 
patients with SSc (10-12). Disability related to impaired hand function may be present in close to 
90% of SSc patients (12,13). The Cochin Hand Function Scale (CHFS) (14) was developed to 
measure functional ability of the hand among patients with rheumatic diseases and has been 
validated (15,16) and used extensively in SSc (8,17-19). The CHFS consists of 18 items that, 
when patient- or clinician-completed, assess the ability to perform daily hand-related activities. 
There are, however, notable redundancies amongst the 18 items. For example, item 13 (Can you 
write a short sentence with a pencil or an ordinary pen?) and item 14 (Can you write a letter 
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with a pencil or an ordinary pen?) may not together provide significantly more information 
beyond what is captured by either item independently. 
Shortening PRO measures would increase the number of outcomes that can be measured 
in studies; however, no standard methods currently exist (20-23). Traditionally, items have been 
deleted based on item-total correlations or the goal of maintaining or improving factorial 
structure by removing items with low factor loadings or high residuals (23,24) or through 
qualitative analysis of item content (23). Modern techniques, such as item response theory (25), 
allow for detailed item evaluation to identify problematic items, but still leave the final selection 
of items to the researcher’s prerogative rather than objective and reproducible criteria.  
Optimal test assembly (OTA) (26), used frequently for item selection in designing high-
stakes educational tests (27), incorporates the results of item response theory models to select the 
optimal subset of an item pool that best satisfies objective, pre-specified constraints, such as 
content- or precision-related requirements. To the best of our knowledge, OTA has not been used 
previously in health research. Nonetheless, these methods have the potential to empirically guide 
the shortening of previously validated PRO measures by optimizing performance based on 
objective, replicable procedures. 
The objective of the present study was to develop a short form of the CHFS using OTA. 
To do this, we: (1) verified the unidimensionality of the scale using confirmatory factor analysis; 
(2) applied OTA methods in order to obtain maximally precise candidate short forms of each 
possible length; and (3) selected the shortest possible short form that demonstrated statistical 
equivalency, based on tests of convergent validity, to the full-length scale. 
PATIENTS AND METHODS 
Sample and Procedure 
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The sample consisted of patients enrolled in the Scleroderma Patient-centered 
Intervention Network (SPIN) Cohort (8) from 21 centers in Canada, the United States, and the 
United Kingdom who completed study questionnaires from March 2014 through June 2015. To 
be included in the SPIN Cohort, patients must have a confirmed diagnosis of SSc according to 
2013 ACR/EULAR classification criteria (28), be ≥ 18 years of age, have the ability to give 
informed consent, be fluent in English or French, and be able to respond to questionnaires via the 
Internet. Eligible patients are invited by SPIN center physicians or supervised nurse coordinators 
to participate, and written informed consent is obtained. To initiate patient registration, the local 
SPIN physician or nurse coordinator completes an online medical data record and an automated 
email is then sent to the patient with instructions for activating their account. Participants 
complete SPIN Cohort measures online upon enrollment and subsequently once every 3 months. 
Only patients with complete CHFS data at baseline in English were included in the present study.  
Measures 
SPIN physicians provided medical information, including time since onset of the first 
non-Raynaud’s phenomenon symptom, SSc subtype (limited or diffuse) (29), modified Rodnan 
skin score, and presence of puffy fingers, sclerodactyly, skin thickening of the fingers, fingertip 
pitting scars, digital ulcers, and small joint contractures (30). Patients provided demographic data 
and completed PROs. 
The 18-item CHFS (14) measures the ability to perform daily hand-related activities. 
Items reflecting five content areas (kitchen, dressing oneself, hygiene, the office, and other) are 
scored on a Likert scale from 0 (yes, without difficulty) to 5 (impossible). Total CHFS scores 
range from 0 to 90, and higher scores indicate more hand disability. The CHFS, when clinician-
completed, has shown excellent intra- and interrater reliability (intraclass correlation coefficients 
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of 0.97 and 0.96, respectively) (14), good convergent validity with functional disability 
measures, and sensitivity to changes in hand function (14,31). Validity and reliability of the self-
report version have been confirmed in SSc (15,16). 
The Health Assessment Questionnaire Disability Index (HAQ-DI) and the Physical 
Function domain of the 29-item Patient Reported Outcomes Measurement Information System 
(PROMIS-29; profile version 1.0 or 2.0) were used to establish convergent validity. The HAQ-
DI assesses disability within 8 categories measured over the past 7 days: dressing/grooming, 
arising, eating, walking, hygiene, reach, grip, and common daily activities. Each item is rated on 
a 4-point scale, ranging from 0 (without any difficulty) to 3 (unable to do). The highest score 
from each category, indicating greater disability, determines the score for that category, and the 
total score is the mean of the 8 category scores, ranging from 0 (no disability) to 3 (severe 
disability). The HAQ-DI is widely used in patients with rheumatologic diseases, and is a valid 
measure of functional disability in SSc (32). 
The Physical Function domain of the PROMIS-29 assesses functional ability. This 
domain consists of four items measuring capacity to complete day-to-day activities, scored on a 
Likert scale from 1 (unable to do) to 5 (without any difficulty). The summed score of the four 
items is standardized based on norms from the general United States population (mean = 50; 
standard deviation = 10). Higher scores indicate greater physical function. The PROMIS-29 and 
its subscales have been shown to be valid measures of health status in SSc (33). 
Statistical Analysis 
To verify the assumption of unidimensionality for the CHFS, a single-factor confirmatory 
factor analysis model was fit to the CHFS data using a robust weighted least squares estimator 
(34). Modification indices were calculated to recognize item pairs for which measurement errors 
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correlated highly. If there was theoretical justification for shared effects within these pairs of 
items, we allowed their errors to covary if this improved model fit (35). Model fit was evaluated 
via a mean- and variance-adjusted chi-square test statistic (34), the Comparative Fit Index (CFI), 
the Tucker-Lewis Index (TLI), and the Root Mean Square Error of Approximation (RMSEA). 
The CFI, TLI and RMSEA indices were prioritized, as the chi-square test may reject models 
despite good fit because it is highly dependent on sample size (36). Values of CFI and TLI ≥ 
0.95 and RMSEA ≤ 0.10 were considered to indicate good fit (37,38). 
Next, a generalized partial credit item response theory model (25,39) was fit to all 18 
CHFS items. For each item, the model estimates (1) thresholds for the levels of disability in hand 
function at which patients are more likely to endorse a given response category instead of the 
category below, and (2) a discrimination parameter, which measures the strength of the 
relationship between that item and the underlying construct, functional disability of the hand (θ). 
Item information functions were then estimated. The test information function (TIF), calculated 
as the sum of the item information functions, measures the total amount of Fisher’s information 
contained in the CHFS as a function of the latent trait, θ. Fisher’s information, which is inversely 
related to standard error of measurement, summarizes the degree of precision of measurements 
of the latent construct (25).  
OTA was then used to create candidate short forms of each possible length by selecting 
items to maximize the TIF (26). Thus, for each possible short form length, a single optimal short 
form, which included a subset of the 18 total CHFS items, was generated. OTA methods use 
mixed integer programming to optimize an objective function subject to a series of user-defined 
constraints. In this case, we adopted a maximin procedure (26,40) to select items that maximized 
the height of each short form’s TIF, maintaining the same relative shape of the full form’s TIF. 
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This approach yields short forms that measure the latent trait with the same relative precision 
across the continuum of the latent trait as the full form, while minimizing absolute loss of 
information. Based on previously established guidelines for best performance of this OTA 
procedure, the relative shape of the TIF was anchored at five points across the spectrum of 
disability in hand function (θ = -1,1,2,3,5) (26). For each candidate short form, the height of the 
TIF and percentage of the full-form TIF maintained in the short form were calculated, as well as 
the average total information across the latent trait spectrum, as a percentage of full-form total 
information. 
For each candidate short form and the full-length form, patients were scored in two ways. 
First, summed scores were computed since summed scores are typically relied upon for clinical 
use. Second, factor scores of disability in hand function, which are assumed to have a standard 
normal distribution in the population, were estimated for each patient via an application of 
Bayes’ theorem. Because of the well-known limitations of the summed score under the 
generalized partial credit model, factor scores were considered to provide a more consistent 
estimate of the latent trait (41,42). 
For each candidate short form and the full-length CHFS, Cronbach’s α was used to assess 
the internal consistency reliability. For concurrent validity, Pearson’s product-moment 
correlation coefficients between summed scores and factor scores on each candidate form with 
summed and factor scores for the full-length form were calculated. Convergent validity was 
assessed via correlations between summed and factor scores on each candidate form and 
summed scores on the HAQ-DI and the PROMIS-29 Physical Function domain. Patients with 
missing data for either of the convergent validity measures were not included in the 
corresponding correlation calculations. We hypothesized that higher scores on the CHFS and its 
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short forms would be associated with higher scores on the HAQ-DI (more disability) but lower 
scores for the PROMIS-29 Physical Function domain (greater physical function). 
OTA methods generate optimal candidate short forms of each possible length, but do not 
readily provide criteria by which to select the best short-form length. By nature of eliminating 
items, the short forms necessarily will have lower information as compared with the full CHFS. 
Beforehand, there is no obvious threshold at which one would conclude that a short form has 
adequate information, so the validity of the short forms must be assessed in order to find a 
balance between shortening the scale and retaining its measurement ability. Thus, two criteria 
were used for selecting which candidate short form should be chosen. First, we required that the 
selected short form maintain high concurrent validity (r > 0.90) and high internal consistency (α 
≥ 0.90) and demonstrate statistical equivalence with the full CHFS for measures of convergent 
validity. Equivalence testing, which has origins in clinical trials, is used to test whether the 
difference between two effect measures (e.g., treatment effect for two drugs) is within a pre-
specified range (43). The equivalence testing paradigm, contrary to traditional hypothesis testing, 
tests a null hypothesis that there will be a difference between the two effect measures equal or 
greater than a pre-specified threshold against the alternative of equivalence or no difference. In 
our study, we specified a null hypothesis that the magnitude of the difference between each 
convergent validity correlation for the candidate short form and its corresponding correlation for 
the full CHFS would be ≥ 0.05 (44). To assess statistical significance, we applied a Bonferonni 
correction factor for each of 66 possible comparisons (summed score and factor score x 2 
measures x 16 short forms of length 2-17 items plus single-item score for 2 measures; p < 
7.58×10
-4
) to maintain the family-wise Type I error rate of α = 0.05. 
The confirmatory factor analysis was done using Mplus 7 (34). All other analyses were 
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done using R version 3.2.1 (45). The generalized partial credit model was fit using the ltm 
package (46). The OTA analysis was conducted using the lpSolveAPI package (47). 
RESULTS 
There were 601 patients who completed the CHFS. Of these, 596 (99%) also completed 
the HAQ-DI, and 595 (99%) completed the PROMIS-29 Physical Function domain. The mean 
age was 55.4 years, 87% were women, and 42% had diffuse SSc. The mean score on the CHFS 
was 14.4 (SD = 16.7). CHFS scores in patients with diffuse SSc were substantially higher than 
patients with limited SSc (see Table 1 for descriptive statistics). 
Confirmatory Factor Analysis  
 A unidimensional confirmatory factor analysis model of the CHFS items, where 
covariance of item residuals was restricted to zero, resulted in less than ideal fit (χ
2
[df = 135] = 
1509.3, p < 0.0001, TLI = 0.966, CFI = 0.970, RMSEA = 0.130). Modification indices suggested 
that allowing residuals of items 9 and 10 and items 13 and 14 to covary would improve model 
fit. Items 9 and 10 both assess the ability to perform actions involved in dressing oneself, and the 
content of items 13 and 14 involves writing with a pencil. The model was refitted, allowing the 
residuals for these two item pairs to covary, and fit improved (χ
2
[df = 133] = 866.0, p < 0.0001, 
TLI = 0.982, CFI = 0.984, RMSEA = 0.096). Factor loadings for the items were all very high (> 
0.82) with the majority over 0.90. 
Item Response Theory Model and Optimal Test Assembly 
The generalized partial credit model was fit to the 18 items of the CHFS. Item content 
along with the discrimination parameters of the model are shown in Table 2. The items with 
greatest discriminative ability and, thus, the greatest influence on the TIF, were items 1 (Can you 
hold a bowl?), 3 (Can you hold a plate full of food?), 7 (Can you prick things well with a fork?), 
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16 (Can you cut a piece of paper with scissors?) and 18 (Can you turn a key in a lock?). Figure 1 
shows the individual item information functions generated by the generalized partial credit 
model and the aggregate TIF. 
 Considering each possible subset of the 18 items, the OTA procedure selected the short 
form of each size that maximally maintained the shape of the TIF for the full-length form. The 
items chosen for each of the short form sizes are shown in Table 3. Several patterns emerged 
from the OTA selection procedure. First, items 12, 13 and 14 were only selected in the longest 
short forms and, thus, quickly dropped from smaller short forms. These items all had low 
discrimination parameters (see Table 2). Second, items 1, 3, 7 and 9 were included in all forms 
of at least 6 items. All of these items had very high information at certain points on the 
continuum of disability or had fairly high information consistently across the continuum. Third, 
some items seemed to alternate in their selection into short forms. For example, items 15 and 18 
were often mutually exclusive in the smaller short form sizes. The content of both items relates 
to opening a lock or door, and there was little added measurement value in including both. 
 The TIFs for each candidate short form are summarized in Table 4. As expected, the 
height of the TIF and percentage of information at each of five points across the latent spectrum 
and average information across the entire spectrum show a consistent decrease in information as 
the length of the form decreases. This drop in information translates into an increase in the 
standard error of measurement for the latent trait as the length of the short form decreases. 
However, despite this loss of information, all internal and external validity correlations remained 
consistently high, even for short forms containing a small number of items (see Appendix Tables 
1 and 2).  
Selection of final short form 
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 The equivalency analysis presented in Table 5 assesses which candidate short forms 
maintained a reasonably equivalent level of concurrent and convergent validity. The 6-item short 
form and all short forms with at least 9 items demonstrated statistically significant equivalence, 
following Bonferroni correction, to all correlations between summed and factor scores of the full 
CHFS with the HAQ-DI and PROMIS-29 Physical Function scores. Although the 5-item short 
form satisfied statistical equivalence for three of the correlations, the correlation between the 
factor scores and the PROMIS-29 Physical Function scores failed to demonstrate equivalence to 
the corresponding full CHFS correlation (p = 0.003 > 7.58×10
-4
). Thus, the 6-item optimal short 
form (CHFS-6; see Appendix 1) was the shortest candidate form to fulfill our equivalence 
requirement. 
 The CHFS-6 had a Cronbach's α of 0.932 and a correlation with the full 18-item CHFS 
scores for summed scores of r = 0.980 (95% confidence interval [CI] 0.976 to 0.983) and factor 
scores of r = 0.970 (95% CI 0.965 to 0.975) (see Appendix Tables 1 and 2). The summed scores 
on the CHFS-6 maintained strong positive correlations with the HAQ-DI (r = 0.790, 95% CI 
0.758 to 0.819) and moderate negative correlations with the PROMIS-29 Physical Function 
domain (r = -0.544, 95% CI -0.599 to -0.485). The TIF of the CHFS-6 as compared to the full 
length form is shown in Figure 1. The CHFS-6 retained, on average, 38.6% of the Fisher 
information of the full form (see Table 4), corresponding to 1.61 times the standard error of 
measurement on average between the short and full forms.  
DISCUSSION 
 This study demonstrated how OTA methods, which have been used extensively in high-
stakes educational testing, may also be used to create valid PRO short forms based on objective, 
pre-specified constraints in health research. The main finding of the study was that the 18-item 
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CHFS could be shortened to a 6-item version (see Appendix 1) with minimal loss of information 
and maintaining high internal validity and similar convergent validity with the HAQ-DI and 
PROMIS-29 Physical Function domain. The summed scores of the CHFS-6 and the full CHFS 
correlated at r = 0.980. Cronbach’s α was 0.932 compared to 0.974 for the full CHFS, and all 
correlations with convergent validity measures were similar and within pre-specified ranges for 
statistical equivalence to the correlations between these measures and the full CHFS. The items 
of the CHFS-6 included three related to eating (holding a bowl; holding a plate of food; holding 
a fork), one elated to food preparation (peeling fruit), one related to dressing (buttoning shirts), 
and one related to the ability to use a key to unlock doors. 
Compared to patients with greater hand disability, the CHFS-6 had relatively higher 
standard error among patients with minimal disability (θ < -1). This occurred for two reasons. 
First, the short-forming procedure prioritized maximizing information where the original form 
measures hand disability well (θ between -1 and 5). Second, the minimal estimated factor score 
for patients in our sample was θ = -1.26, resulting in little data from patients in the lower end. 
The exact specification of the OTA procedure that we used resulted in candidate short 
forms that were not required to be nested, meaning that the items of one short form were not 
required to be contained in all larger short forms. For example, item 8 is in the 2-item short form, 
but does not appear in the 3-item or 4-item forms. This reflects the shape-maintaining property of 
our OTA specification that allows for a push-and-pull dynamic between items that have more 
information at different locations of the latent trait continuum. However, if the creation of nested 
short forms is desired, the methodology used in this study could be easily adapted to satisfy this 
constraint by selecting each subsequent optimal candidate short form only from the items 
appearing on the optimal short form one item longer. Similarly, OTA does not automatically 
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consider content validity, but these constraints such as setting a maximum number of items per 
content area may be added as desired. However, if a short form indeed performs virtually 
equivalently to its parent form, despite the lack of content in some sub-areas due to elimination 
of items, this suggests that the content may not be necessary for optimal measurement, regardless 
of theoretical suggestions otherwise. 
Although this study focused on the development and validation of a short form of the 
CHFS for patients with SSc, the OTA approach that we used could be applied with other patient 
populations and other measures for developing short forms of PRO measures. The present study, 
however, represents only a first step in using OTA methods to attempt to standardize processes 
for developing optimally functioning shortened PRO measures in health research. The SPIN 
Cohort is a convenience sample, and therefore may not be representative of the SSc population. 
Patients in the present study, for instance, had somewhat lower hand disability, on average, 
compared to other SSc cohorts where the CHFS has been used (15,16). 
Further research is needed to determine the robustness of the OTA procedure with other 
measures and patient cohorts and to compare to other short-forming methods. The Bonferroni 
correction used to account for issues of multiple testing may be overly conservative, albeit easily 
applied, and alternative approaches may be preferred. Furthermore, additional research is needed 
on how best to use OTA to shorten scales in the context of multidimensionality. Finally, OTA is 
an exploratory, data-driven approach, and results of this study should be replicated. 
 In sum, this study demonstrated how OTA methods can be used to develop and validate 
short forms of PRO measures based on pre-specified and objective criteria for determining both 
the number of items to include in the short form and the specific items to be included. 
Application of OTA methods to the 18-item CHFS in a large sample of SSc patients resulted in a 
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6-item version with minimal loss of information and minimal change to indices of reliability and 
convergent validity compared to the 18-item form.  
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Table 1. Patient demographic and disease characteristics (N = 601) 
Sociodemographic variables Values 
Age, years; mean ± SD (range) 55.4 ± 11.9 (18.6 – 84.7) 
Women; n (%) 524 (87) 
Education >12 years; n (%) 483 (80) 
Currently employed; n (%) 248 (41) 
Married / cohabitating; n (%) 442 (74) 
Time since the onset of the first non-Raynaud’s symptoms, years
a
; mean ± SD (range) 11.8 ± 8.8 (0.1 – 46.2) 
Patients with diffuse SSc
b
; n (%) 250 (42) 
MRSS
c
; mean ± SD (range) 8.2 ± 9.2 (0 – 48) 
Puffy fingers
d
; n (%) 371 (65) 
Sclerodactyly
e
; n (%) 503 (84) 
Skin thickening of the fingers
f
; n (%) 338 (56) 
Fingertip pitting scars
g
; n (%) 250 (42) 
Digital ulcers
h,i
; n (%) 229 (40) 
Moderate to severe small joint contractures
j
; n (%) 145 (25) 
CHFS score; mean [median] ± SD (range) 14.4 [8] ± 16.7 (0 – 88) 
Mean score [median] ± SD (range) in diffuse SSc subset 20.5 [15] ± 19.2 (0 – 88) 
Mean score [median] ± SD (range) in limited SSc subset 10.0 [4] ± 12.9 (0 – 62) 
HAQ-DI score
k
; mean [median] ± SD (range) 0.81 [0.75] ± 0.69 (0 – 3) 
PROMIS-29 Physical Function score
l
; mean [median] ± SD (range) 42.5 [41.8] ± 8.7 (22.9 – 56.9) 
Abbreviations: n = number; SD = standard deviation; CHFS = Cochin Hand Function Scale; MRSS = modified 
Rodnan skin score; SSc = systemic sclerosis; HAQ-DI = Health Assessment Questionnaire disability index; 
PROMIS-29 = 29-item Patient Reported Outcomes Measurement Information System. 
 
i
Considered to have digitial ulcer if had digital pulp (volar), distal to distal interphalangeal joints, or elsewhere 
on the finger, and provided a response to both of these items. 
 






N = 503; 
d
N = 571; 
e
N = 598; 
f









N = 596; 
l
N = 595  
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Table 2. CHFS items and discrimination parameters from the generalized partial credit 
model 
 
Item Number Description 
Discrimination 
Parameter 
1 Can you hold a bowl? 2.33 
2 Can you seize a full bottle and raise it? 1.84 
3 Can you hold a plate full of food? 2.25 
4 Can you pour liquid from a bottle into a glass? 2.10 
5 Can you unscrew the lid from a jar opened before? 1.27 
6 Can you cut meat with a knife? 1.98 
7 Can you prick things well with a fork? 2.65 
8 Can you peel fruit? 1.92 
9 Can you button your shirt? 1.76 
10 Can you open and close a zipper? 1.99 
11 Can you squeeze a new tube of toothpaste? 1.61 
12 Can you hold a toothbrush efficiently? 1.66 
13 Can you write a short sentence with a pencil or an ordinary pen? 1.52 
14 Can you write a letter with a pencil or an ordinary pen? 1.23 
15 Can you turn a round door knob? 2.11 
16 Can you cut a piece of paper with scissors? 2.29 
17 Can you pick up coins from a table top? 1.41 
18 Can you turn a key in a lock? 2.32 
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Table 3. Optimal short forms of each length 



























































1                  X 
2       X X           
3       X  X         X 
4       X  X X     X    
5 X      X X X         X 
6 X  X    X X X         X 
7 X  X    X  X      X X X  
8 X  X    X  X      X X X X 
9 X  X X   X X X       X X X 
10 X  X X   X X X X     X X X  
11 X  X X   X X X X     X X X X 
12 X X X X  X X X X X     X  X X 
13 X X X X X  X X X X     X X X X 
14 X X X X X X X X X X X     X X X 
15 X X X X X X X X X X X    X X X X 
16 X X X X X X X X X X X  X  X X X X 
17 X X X X X X X X X X X X  X X X X X 
18 X X X X X X X X X X X X X X X X X X 
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Table 4. Test information values for optimal short forms 
Bold values represent those of the final selected short form. 
 Test Information Function (% of full form)  
Short Form 
Length 
θ = -1 θ = 1 θ = 2 θ = 3 θ = 5 
Average Information 
(% of full form) 
1 0.14 (4.6) 3.16 (8.1) 3.13 (6.8) 2.34 (5.4) 0.25 (4.5) 6.8 
2 0.37 (12.4) 4.51 (11.6) 7.66 (16.7) 5.71 (13.0) 0.77 (13.6) 13.3 
3 0.57 (19.1) 7.57 (19.5) 8.87 (19.3) 8.72 (19.9) 1.11 (19.7) 19.7 
4 0.72 (24.2) 9.66 (24.9) 11.61 (25.3) 10.63 (24.3) 1.73 (30.8) 24.9 
5 1.00 (33.4) 12.10 (31.2) 15.39 (33.5) 13.61 (31.1) 1.88 (33.4) 32.1 
6 1.08 (36.0) 14.43 (37.2) 17.92 (39.0) 16.82 (38.4) 2.69 (47.8) 38.6 
7 1.30 (43.6) 16.62 (42.8) 19.59 (42.7) 19.69 (44.9) 2.73 (48.5) 43.2 
8 1.44 (48.1) 19.79 (51.0) 22.72 (49.5) 22.03 (50.3) 2.98 (53.0) 50.0 
9 1.69 (56.6) 21.50 (55.4) 25.60 (55.8) 24.64 (56.2) 3.07 (54.6) 55.6 
10 1.85 (61.7) 23.58 (60.7) 28.34 (61.8) 26.55 (60.6) 3.70 (65.8) 60.8 
11 1.99 (66.3) 26.75 (68.9) 31.47 (68.6) 28.90 (66.0) 3.95 (70.3) 67.6 
12 2.14 (71.7) 28.65 (73.8) 32.83 (71.5) 31.29 (71.4) 4.15 (73.8) 72.0 
13 2.40 (80.3) 30.13 (77.6) 35.19 (76.7) 33.77 (77.1) 4.25 (75.7) 76.7 
14 2.43 (81.2) 31.39 (80.8) 36.80 (80.2) 35.72 (81.5) 4.77 (84.9) 81.0 
15 2.60 (86.9) 34.13 (87.9) 40.29 (87.8) 38.15 (87.1) 4.85 (86.2) 87.1 
16 2.72 (90.9) 35.66 (91.8) 42.03 (91.6) 40.30 (92.0) 5.14 (91.5) 91.6 
17 2.87 (96.0) 37.30 (96.1) 44.15 (96.2) 41.67 (95.1) 5.32 (94.7) 95.6 
18 2.99 (100.0) 38.83 (100.0) 45.89 (100.0) 43.82 (100.0) 5.62 (100.0) 100.0 
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Table 5. Equivalency analysis results 
 
 
Difference in external validity correlations of summed and factor scores of full Cochin Hand Function 
Scale and candidate short versions [rfull – rshort], and p-values for equivalency within ± 0.05 
 HAQ-DI Score Correlation PROMIS-29 Physical Function Correlation 
Short Form 
Length 
Summed Score Factor Score Summed Score Factor Score 
1 0.093 (p > 0.99) NA -0.071 (p = 0.89) NA 
2 0.077 (p > 0.99) 0.080 (p > 0.99) -0.060 (p = 0.78) -0.069 (p = 0.90) 
3 0.040 (p = 0.09) 0.045 (p = 0.28) -0.038 (p = 0.13) -0.045 (p = 0.34) 
4 0.045 (p = 0.24) 0.051 (p = 0.53) -0.043 (p = 0.25) -0.047 (p = 0.40) 
5 0.025 (p < 0.0001) 0.026 (p < 0.0001) -0.025 (p < 0.001) -0.026 (p < 0.01) 
6 0.016 (p < 0.0001) 0.015 (p < 0.0001) -0.017 (p < 0.0001) -0.016 (p < 0.0001) 
7 0.023 (p < 0.0001) 0.025 (p < 0.0001) -0.035 (p < 0.01) -0.041 (p = 0.12) 
8 0.020 (p < 0.0001) 0.020 (p < 0.0001) -0.031 (p < 0.001) -0.036 (p = 0.02) 
9 0.015 (p < 0.0001) 0.014 (p < 0.0001) -0.019 (p < 0.0001) -0.019 (p < 0.0001) 
10 0.017 (p < 0.0001) 0.017 (p < 0.0001) -0.021 (p < 0.0001) -0.022 (p < 0.0001) 
11 0.014 (p < 0.0001) 0.015 (p < 0.0001) -0.019 (p < 0.0001) -0.020 (p < 0.0001) 
12 0.005 (p < 0.0001) 0.005 (p < 0.0001) -0.008 (p < 0.0001) -0.007 (p < 0.0001) 
13 0.005 (p < 0.0001) 0.005 (p < 0.0001) -0.008 (p < 0.0001) -0.009 (p < 0.0001) 
14 0.001 (p < 0.0001) 0.000 (p < 0.0001) -0.005 (p < 0.0001) -0.005 (p < 0.0001) 
15 0.002 (p < 0.0001) 0.001 (p < 0.0001) -0.008 (p < 0.0001) -0.009 (p < 0.0001) 
16 0.002 (p < 0.0001) 0.000 (p < 0.0001) -0.006 (p < 0.0001) -0.005 (p < 0.0001) 
17 -0.001 (p < 0.0001) -0.001 (p < 0.0001) -0.001 (p < 0.0001) -0.002 (p < 0.0001) 
Bold values represent those of the final selected short form.
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Figure 1. Item and test information curves of the CHFS. The left hand plot shows the 18 individual item information curves, labelled 
by color. The right hand plot compares the test information functions of the full CHFS (solid line) and CHFS-6 (dashed line)
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APPENDIX 1: The Cochin Hand Function Scale 6-Item Short Form (CHFS-6) 
 
















to do Impossible 
1. Can you hold a bowl?        
2. Can you hold a plate full of food?       
3. Can you prick things well with a fork?       
4. Can you peel fruit?       
5. Can you button your shirt?       
6. Can you turn a key in a lock?       
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Correlation of Summed 
Score with Full Form 
Score (95% CI) 
Correlation of Summed 
Score with HAQ-DI Score 
(95% CI) 
Correlation of Summed Score with 
PROMIS-29 Physical Function Score 
(95% CI) 
1 NA 0.877 (0.857, 0.894) 0.714 (0.672, 0.751) -0.490 (-0.549, -0.427) 
2 0.796 0.925 (0.913, 0.936) 0.730 (0.690, 0.765) -0.501 (-0.559, -0.439) 
3 0.865 0.954 (0.946, 0.961) 0.766 (0.731, 0.798) -0.523 (-0.579, -0.462) 
4 0.912 0.956 (0.949, 0.963) 0.762 (0.726, 0.794) -0.518 (-0.574, -0.457) 
5 0.919 0.974 (0.970, 0.978) 0.782 (0.749, 0.811) -0.537 (-0.592, -0.477) 
6 0.932 0.980 (0.976, 0.983) 0.790 (0.758, 0.819) -0.544 (-0.599, -0.485) 
7 0.939 0.983 (0.980, 0.985) 0.783 (0.750, 0.812) -0.526 (-0.582, -0.466) 
8 0.949 0.985 (0.982, 0.987) 0.787 (0.755, 0.816) -0.531 (-0.586, -0.470) 
9 0.953 0.988 (0.985, 0.989) 0.791 (0.759, 0.820) -0.542 (-0.596, -0.483) 
10 0.959 0.989 (0.987, 0.991) 0.790 (0.758, 0.818) -0.540 (-0.595, -0.481) 
11 0.964 0.990 (0.988, 0.992) 0.792 (0.760, 0.820) -0.542 (-0.596, -0.482) 
12 0.966 0.993 (0.991, 0.994) 0.802 (0.771, 0.828) -0.554 (-0.607, -0.495) 
13 0.967 0.993 (0.992, 0.994) 0.802 (0.771, 0.829) -0.554 (-0.607, -0.495) 
14 0.968 0.995 (0.994, 0.996) 0.805 (0.775, 0.832) -0.556 (-0.609, -0.498) 
15 0.971 0.996 (0.995, 0.997) 0.805 (0.774, 0.831) -0.553 (-0.607, -0.495) 
16 0.972 0.998 (0.998, 0.999) 0.805 (0.774, 0.831) -0.555 (-0.609, -0.497) 
17 0.973 0.999 (0.999, 0.999) 0.808 (0.778, 0.834) -0.560 (-0.613, -0.503) 
18 0.974 1.000 (1.000, 1.000) 0.807 (0.777, 0.833) -0.561 (-0.614, -0.504) 
Bold values represent those of the final selected short form. 
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Correlation of Factor Score with 
Full Form Factor Score (95% CI) 
Correlation of Factor Score with 
HAQ-DI Score (95% CI) 
Correlation of Factor Score with PROMIS-29 
Physical Function Score (95% CI) 
1 NA NA NA 
2 0.892 (0.875, 0.908) 0.742 (0.704, 0.776) -0.527 (-0.583, -0.467) 
3 0.937 (0.927, 0.946) 0.777 (0.743, 0.807) -0.551 (-0.605, -0.493) 
4 0.941 (0.931, 0.950) 0.772 (0.737, 0.802) -0.549 (-0.603, -0.491) 
5 0.965 (0.959, 0.970) 0.796 (0.765, 0.824) -0.570 (-0.622, -0.514) 
6 0.970 (0.965, 0.975) 0.807 (0.777, 0.833) -0.581 (-0.632, -0.525) 
7 0.974 (0.969, 0.978) 0.797 (0.766, 0.824) -0.556 (-0.609, -0.497) 
8 0.978 (0.975, 0.981) 0.802 (0.771, 0.829) -0.561 (-0.614, -0.503) 
9 0.984 (0.982, 0.987) 0.808 (0.778, 0.834) -0.578 (-0.629, -0.521) 
10 0.985 (0.983, 0.987) 0.805 (0.775, 0.832) -0.575 (-0.626, -0.519) 
11 0.987 (0.985, 0.989) 0.808 (0.778, 0.834) -0.577 (-0.628, -0.521) 
12 0.990 (0.988, 0.991) 0.817 (0.788, 0.842) -0.589 (-0.639, -0.534) 
13 0.992 (0.991, 0.993) 0.817 (0.788, 0.842) -0.588 (-0.638, -0.533) 
14 0.994 (0.993, 0.995) 0.822 (0.794, 0.847) -0.591 (-0.641, -0.536) 
15 0.995 (0.994, 0.996) 0.821 (0.793, 0.846) -0.588 (-0.638, -0.533) 
16 0.998 (0.998, 0.998) 0.822 (0.794, 0.846) -0.592 (-0.642, -0.537) 
17 0.999 (0.999, 0.999) 0.823 (0.795, 0.847) -0.594 (-0.644, -0.540) 
18 1.000 (1.000, 1.000) 0.822 (0.794, 0.847) -0.597 (-0.646, -0.542) 
Bold values represent those of the final selected short form. 
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